Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Mantarray revolutionizes the early phases of preclinical drug testing by integrating functional data with advanced technologies. By enabling simultaneous analysis of 3D engineered muscle tissues that exhibit adult-like functional characteristics, Mantarray facilitates the identification, safety assessment, and effectiveness evaluation of new therapeutics. With an impressive tissue formation success rate exceeding 95%, the Mantarray Plate Kit ensures consistent and reproducible engineered tissues across 24 wells. This innovative platform offers a user-friendly, scalable, and adaptable solution that empowers researchers to analyze 3D tissues in vitro right within their labs. Early adopters can take advantage of this groundbreaking instrument. The Mantarray system employs a unique magnetic sensing method that accurately detects the contractions of engineered muscle tissues (EMTs), allowing users to assess the contractility of 24 tissues simultaneously and in real time, greatly enhancing throughput. Moreover, the accompanying software simplifies the process by eliminating the need for manual contractility calculations, thus streamlining the research workflow. Overall, Mantarray not only improves the efficiency of drug discovery but also enhances the reliability of data obtained during preclinical studies.
Description
Harnessing RNA sequencing (RNA-seq) data alongside Artificial Intelligence presents both a crucial necessity and a significant opportunity for creating therapies aimed at correcting splicing errors. By leveraging machine learning, we can uncover novel splicing errors and swiftly formulate therapeutic compounds to address them. Our AI platform, SpliceCore, is specifically designed for discovering RNA therapeutics. This cutting-edge technology focuses on analyzing RNA sequencing data with unparalleled efficiency. It can swiftly identify, evaluate, and validate potential drug targets, outpacing traditional methodologies. Central to SpliceCore is our unique repository containing over 5 million potential RNA splicing errors, making it the largest of its kind globally and instrumental for testing any RNA sequencing dataset submitted for analysis. The integration of scalable cloud computing allows us to handle vast quantities of RNA sequencing data in a way that is not only efficient but also cost-effective, significantly speeding up the pace of therapeutic advancements. This innovative approach promises to revolutionize the landscape of RNA therapeutics.
API Access
Has API
No
API Access
Has API
No
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
Yes
Live Training (Online)
No
In Person
Yes
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
No
In Person
Yes
Vendor Details
Company Name
Curi Bio
Founded
2015
Country
United States
Website
www.curibio.com/mantarray
Vendor Details
Company Name
Envisagenics
Founded
2014
Country
United States
Website
www.envisagenics.com/platform/